
Australia
Percheron Therapeutics Completes Key Toxicology Study for Avicursen Ahead of US FDA Clinical Trials
Australian biotechnology company Percheron Therapeutics (ASX: PER) has achieved a critical mileston…
Exclusive segment for our readers to dive deep into the most fascinating new developments in Healthcare, Mining, Fashion, Finance, Science & Technology and much more.











COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.